US equities
|
NVDA
$150.96
▼-2.89%
MU
$705.27
▼-1.00%
AMD
$530.14
▲+5.31%
SPCX
$143.50
▲+1.27%
AAPL
$352.45
▲+0.15%
MSFT
$508.29
▲+0.40%
AMZN
$267.74
▲+3.82%
TSLA
$383.72
▲+0.95%
NVDA
$150.96
▼-2.89%
MU
$705.27
▼-1.00%
AMD
$530.14
▲+5.31%
SPCX
$143.50
▲+1.27%
AAPL
$352.45
▲+0.15%
MSFT
$508.29
▲+0.40%
AMZN
$267.74
▲+3.82%
TSLA
$383.72
▲+0.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Align Technology, Inc. - Common Stock
(NQ:
ALGN
)
163.96
+0.50 (+0.31%)
Delayed Quote
Updated: 4:00 PM EST, Nov 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Align Technology, Inc. - Common Stock
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
Three Medical Stocks To Watch, Including One With A Potential Breakout
↗
April 22, 2021
Two have recent breakouts under their belts while a third is eyeing a fresh buy point.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2021
↗
April 22, 2021
Upgrades Barclays upgraded the previous rating for SolarEdge Technologies Inc (NASDAQ:SEDG) from Equal-Weight to Overweight. In the fourth quarter, SolarEdge Technologies...
Via
Benzinga
Align Technology Nears Buy Point With Earnings Due
↗
April 21, 2021
Align Technology is near a possible buy zone ahead of its next quarterly earnings report, expected on or around April 28.
Via
Investor's Business Daily
Cancer Therapy Novocure Stock Still On A High As It Clears Technical Benchmark
↗
April 21, 2021
Cancer therapy Novocure stock had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. It's also an IBD 50 member.
Via
Investor's Business Daily
3 Top Value Stocks in Healthcare to Buy Right Now
↗
April 21, 2021
Well-known guidance from Warren Buffett can help us identify opportunities in an expensive market.
Via
The Motley Fool
Cancer Therapy Novocure Stock Flashes Renewed Technical Strength
↗
April 14, 2021
Novocure stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 67 to 92.
Via
Investor's Business Daily
Markets Set New All-Time Closing Highs. Here's Why.
↗
April 08, 2021
The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) had an impressive day of trading Thursday with the fund seeing gains of 1.04% finishing at $335.08. Major indices were trading...
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >